Skip to main content
Top
Published in: Strahlentherapie und Onkologie 2/2023

24-06-2022 | NSCLC | Original Article

CircDLG1 promotes malignant development of non-small cell lung cancer through regulation of the miR-630/CENPF axis

Authors: Yingying Chen, Ying Zhang

Published in: Strahlentherapie und Onkologie | Issue 2/2023

Login to get access

Abstract

Background

Circular RNAs (circRNAs) have been reported to be crucial modulatory molecules in the etiology of non-small cell lung cancer (NSCLC). This study aimed to probe the precise role and mechanism of circRNA discs large MAGUK scaffold protein 1 (circDLG1) in the malignant progression of NSCLC.

Methods

The abundances of circDLG1, miR-630, and centromere protein F (CENPF) mRNAs were gauged by quantitative real-time polymerase chain reaction (qRT-PCR). Cell proliferation was tested in 3‑(4, 5‑dimethylthiazol-2-yl)-2, 5‑diphenyltetrazolium bromide (MTT) assay and 5‑ethynyl-2′-deoxyuridine (EdU)-incorporation assay. Cell apoptosis was analyzed by flow cytometry. Cell migration and invasion were assessed by transwell assay. Western blot was exploited to examine the levels of all proteins. The interaction between miR-630 and circDLG1 or CENPF was verified by dual-luciferase reporter, RNA pull-down, and/or RNA immunoprecipitation assays. Tumor xenograft assay and immunohistochemistry (IHC) were executed for the role of circDLG1 in tumor growth in vivo.

Results

CircDLG1 and CENPF were highly expressed in NSCLC, while miR-630 was downregulated. CircDLG1 silencing repressed proliferation, migration, and invasion, and expedited apoptosis of NSCLC cells in vitro. Mechanistically, circDLG1 deficiency modulated NSCLC cell malignant development through interacting with miR-630. Furthermore, CENPF was targeted by miR-630, and circDLG1 could positively control CENPF expression through acting as an miR-630 sponge. Furthermore, CENPF overexpression reversed the repressive impacts of circDLG1 inhibition in the malignant behaviors of NSCLC cells. Besides, circDLG1 interference hindered tumor growth in vivo.

Conclusion

CircDLG1 knockdown could impede NSCLC advancement through modulating the miR-630/CENPF axis, manifesting as a promising molecular target for NSCLC treatment.
Literature
1.
go back to reference Schwartz AG, Cote ML (2016) Epidemiology of lung cancer. Adv Exp Med Biol 893:21–41CrossRef Schwartz AG, Cote ML (2016) Epidemiology of lung cancer. Adv Exp Med Biol 893:21–41CrossRef
2.
go back to reference Herbst RS, Morgensztern D, Boshoff C (2018) The biology and management of non-small cell lung cancer. Nature 553(7689):446–454CrossRef Herbst RS, Morgensztern D, Boshoff C (2018) The biology and management of non-small cell lung cancer. Nature 553(7689):446–454CrossRef
3.
go back to reference Nagano T, Tachihara M, Nishimura Y (2019) Molecular mechanisms and targeted therapies including immunotherapy for non-small cell lung cancer. Curr Cancer Drug Targets 19(8):595–630CrossRef Nagano T, Tachihara M, Nishimura Y (2019) Molecular mechanisms and targeted therapies including immunotherapy for non-small cell lung cancer. Curr Cancer Drug Targets 19(8):595–630CrossRef
4.
go back to reference Imyanitov EN, Iyevleva AG, Levchenko EV (2021) Molecular testing and targeted therapy for non-small cell lung cancer: current status and perspectives. Crit Rev Oncol Hematol 157:103194CrossRef Imyanitov EN, Iyevleva AG, Levchenko EV (2021) Molecular testing and targeted therapy for non-small cell lung cancer: current status and perspectives. Crit Rev Oncol Hematol 157:103194CrossRef
5.
go back to reference Qian L, Yu S, Chen Z, Meng Z, Huang S, Wang P (2018) The emerging role of circRNAs and their clinical significance in human cancers. Biochim Biophys Acta Rev Cancer 1870(2):247–260CrossRef Qian L, Yu S, Chen Z, Meng Z, Huang S, Wang P (2018) The emerging role of circRNAs and their clinical significance in human cancers. Biochim Biophys Acta Rev Cancer 1870(2):247–260CrossRef
6.
go back to reference Chen LL, Yang L (2015) Regulation of circRNA biogenesis. RNA Biol 12(4):381–388CrossRef Chen LL, Yang L (2015) Regulation of circRNA biogenesis. RNA Biol 12(4):381–388CrossRef
7.
go back to reference Cui C, Yang J, Li X, Liu D, Fu L, Wang X (2020) Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance. Mol Cancer 19(1):58CrossRef Cui C, Yang J, Li X, Liu D, Fu L, Wang X (2020) Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance. Mol Cancer 19(1):58CrossRef
8.
go back to reference He J, Xie Q, Xu H, Li J, Li Y (2017) Circular RNAs and cancer. Cancer Lett 396:138–144CrossRef He J, Xie Q, Xu H, Li J, Li Y (2017) Circular RNAs and cancer. Cancer Lett 396:138–144CrossRef
9.
go back to reference Xu N, Chen S, Liu Y, Li W, Liu Z, Bian X, Ling C, Jiang M (2018) Profiles and bioinformatics analysis of differentially expressed circrnas in taxol-resistant non-small cell lung cancer cells. Cell Physiol Biochem 48(5):2046–2060CrossRef Xu N, Chen S, Liu Y, Li W, Liu Z, Bian X, Ling C, Jiang M (2018) Profiles and bioinformatics analysis of differentially expressed circrnas in taxol-resistant non-small cell lung cancer cells. Cell Physiol Biochem 48(5):2046–2060CrossRef
11.
go back to reference Guan S, Li L, Chen WS, Jiang WY, Ding Y, Zhao LL, Shi YF, Wang J, Gui Q, Xu CC et al (2021) Circular RNA WHSC1 exerts oncogenic properties by regulating miR-7/TAB2 in lung cancer. J Cell Mol Med 25(20):9784–9795. https://doi.org/10.1111/jcmm.16925CrossRef Guan S, Li L, Chen WS, Jiang WY, Ding Y, Zhao LL, Shi YF, Wang J, Gui Q, Xu CC et al (2021) Circular RNA WHSC1 exerts oncogenic properties by regulating miR-7/TAB2 in lung cancer. J Cell Mol Med 25(20):9784–9795. https://​doi.​org/​10.​1111/​jcmm.​16925CrossRef
12.
go back to reference Hu X, Wang P, Qu C, Zhang H, Li L (2021) Circular RNA Circ_0000677 promotes cell proliferation by regulating microRNA-106b-5p/CCND1 in non-small cell lung cancer. Bioengineered 12(1):6229–6239CrossRef Hu X, Wang P, Qu C, Zhang H, Li L (2021) Circular RNA Circ_0000677 promotes cell proliferation by regulating microRNA-106b-5p/CCND1 in non-small cell lung cancer. Bioengineered 12(1):6229–6239CrossRef
13.
go back to reference O’Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) 9:402CrossRef O’Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) 9:402CrossRef
14.
go back to reference Lu TX, Rothenberg ME (2018) MicroRNA. J Allergy Clin Immunol 141(4):1202–1207CrossRef Lu TX, Rothenberg ME (2018) MicroRNA. J Allergy Clin Immunol 141(4):1202–1207CrossRef
15.
go back to reference Mendell JT, Olson EN (2012) MicroRNAs in stress signaling and human disease. Cell 148(6):1172–1187CrossRef Mendell JT, Olson EN (2012) MicroRNAs in stress signaling and human disease. Cell 148(6):1172–1187CrossRef
16.
go back to reference Peng Y, Croce CM (2016) The role of MicroRNAs in human cancer. Signal Transduct Target Ther 1:15004CrossRef Peng Y, Croce CM (2016) The role of MicroRNAs in human cancer. Signal Transduct Target Ther 1:15004CrossRef
17.
go back to reference Bhaskaran M, Mohan M (2014) MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet Pathol 51(4):759–774CrossRef Bhaskaran M, Mohan M (2014) MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet Pathol 51(4):759–774CrossRef
18.
go back to reference Feng B, Zhang K, Wang R, Chen L (2015) Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment. Clin Sci (Lond) 128(10):619–634CrossRef Feng B, Zhang K, Wang R, Chen L (2015) Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment. Clin Sci (Lond) 128(10):619–634CrossRef
19.
go back to reference Song YF, Hong JF, Liu DL, Lin QA, Lan XP, Lai GX (2015) miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer. Am J Transl Res 7(7):1271–1279 Song YF, Hong JF, Liu DL, Lin QA, Lan XP, Lai GX (2015) miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer. Am J Transl Res 7(7):1271–1279
20.
go back to reference Li MX, Zhang MY, Dong HH, Li AJ, Teng HF, Liu AL, Xu N, Qu YQ (2021) Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma. Int J Med Sci 18(2):494–504CrossRef Li MX, Zhang MY, Dong HH, Li AJ, Teng HF, Liu AL, Xu N, Qu YQ (2021) Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma. Int J Med Sci 18(2):494–504CrossRef
21.
go back to reference Hexiao T, Yuquan B, Lecai X, Yanhong W, Li S, Weidong H, Ming X, Xuefeng Z, Gaofeng P, Li Z et al (2021) Knockdown of CENPF inhibits the progression of lung adenocarcinoma mediated by ERbeta2/5 pathway. Aging (Albany NY) 13(2):2604–2625CrossRef Hexiao T, Yuquan B, Lecai X, Yanhong W, Li S, Weidong H, Ming X, Xuefeng Z, Gaofeng P, Li Z et al (2021) Knockdown of CENPF inhibits the progression of lung adenocarcinoma mediated by ERbeta2/5 pathway. Aging (Albany NY) 13(2):2604–2625CrossRef
22.
go back to reference Wang C, Tan S, Liu WR, Lei Q, Qiao W, Wu Y, Liu X, Cheng W, Wei YQ, Peng Y et al (2019) RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma. Mol Cancer 18(1):134CrossRef Wang C, Tan S, Liu WR, Lei Q, Qiao W, Wu Y, Liu X, Cheng W, Wei YQ, Peng Y et al (2019) RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma. Mol Cancer 18(1):134CrossRef
23.
go back to reference Arnaiz E, Sole C, Manterola L, Iparraguirre L, Otaegui D, Lawrie CH (2019) CircRNAs and cancer: biomarkers and master regulators. Semin Cancer Biol 58:90–99CrossRef Arnaiz E, Sole C, Manterola L, Iparraguirre L, Otaegui D, Lawrie CH (2019) CircRNAs and cancer: biomarkers and master regulators. Semin Cancer Biol 58:90–99CrossRef
24.
go back to reference Huang X, Zhang W, Shao Z (2019) Prognostic and diagnostic significance of circRNAs expression in lung cancer. J Cell Physiol 234(10):18459–18465CrossRef Huang X, Zhang W, Shao Z (2019) Prognostic and diagnostic significance of circRNAs expression in lung cancer. J Cell Physiol 234(10):18459–18465CrossRef
25.
go back to reference Di X, Jin X, Li R, Zhao M, Wang K (2019) CircRNAs and lung cancer: biomarkers and master regulators. Life Sci 220:177–185CrossRef Di X, Jin X, Li R, Zhao M, Wang K (2019) CircRNAs and lung cancer: biomarkers and master regulators. Life Sci 220:177–185CrossRef
26.
go back to reference Li S, Liu Y, Qiu G, Luo Y, Li X, Meng F, Li N, Xu T, Wang Y, Qin B et al (2021) Emerging roles of circular RNAs in nonsmall cell lung cancer (review). Oncol Rep 45(4):17CrossRef Li S, Liu Y, Qiu G, Luo Y, Li X, Meng F, Li N, Xu T, Wang Y, Qin B et al (2021) Emerging roles of circular RNAs in nonsmall cell lung cancer (review). Oncol Rep 45(4):17CrossRef
27.
go back to reference Sun Q, Li X, Xu M, Zhang L, Zuo H, Xin Y, Zhang L, Gong P (2020) Differential expression and bioinformatics analysis of circRNA in non-small cell lung cancer. Front Genet 11:586814CrossRef Sun Q, Li X, Xu M, Zhang L, Zuo H, Xin Y, Zhang L, Gong P (2020) Differential expression and bioinformatics analysis of circRNA in non-small cell lung cancer. Front Genet 11:586814CrossRef
29.
go back to reference Song HM, Meng D, Wang JP, Zhang XY (2021) circRNA hsa_circ_0005909 predicts poor prognosis and promotes the growth, metastasis, and drug resistance of non-small-cell lung cancer via the miRNA-338-3p/SOX4 pathway. Dis Markers 2021:8388512CrossRef Song HM, Meng D, Wang JP, Zhang XY (2021) circRNA hsa_circ_0005909 predicts poor prognosis and promotes the growth, metastasis, and drug resistance of non-small-cell lung cancer via the miRNA-338-3p/SOX4 pathway. Dis Markers 2021:8388512CrossRef
30.
go back to reference Zhang H, Shen Y, Li Z, Ruan Y, Li T, Xiao B, Sun W (2020) The biogenesis and biological functions of circular RNAs and their molecular diagnostic values in cancers. J Clin Lab Anal 34(1):e23049CrossRef Zhang H, Shen Y, Li Z, Ruan Y, Li T, Xiao B, Sun W (2020) The biogenesis and biological functions of circular RNAs and their molecular diagnostic values in cancers. J Clin Lab Anal 34(1):e23049CrossRef
31.
go back to reference Rong J, Wang Q, Zhang Y, Zhu D, Sun H, Tang W, Wang R, Shi W, Cao XF (2018) Circ-DLG1 promotes the proliferation of esophageal squamous cell carcinoma. Onco Targets Ther 11:6723–6730CrossRef Rong J, Wang Q, Zhang Y, Zhu D, Sun H, Tang W, Wang R, Shi W, Cao XF (2018) Circ-DLG1 promotes the proliferation of esophageal squamous cell carcinoma. Onco Targets Ther 11:6723–6730CrossRef
32.
go back to reference Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M (2013) Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495(7441):333–338CrossRef Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M (2013) Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495(7441):333–338CrossRef
33.
go back to reference Panda AC (2018) Circular RNAs Act as miRNA sponges. Adv Exp Med Biol 1087:67–79CrossRef Panda AC (2018) Circular RNAs Act as miRNA sponges. Adv Exp Med Biol 1087:67–79CrossRef
34.
go back to reference Liu DY, Li Z, Zhang K, Jiao N, Lu DG, Zhou DW, Meng YB, Sun L (2021) Circular RNA CircMTO1 suppressed proliferation and metastasis of osteosarcoma through miR-630/KLF6 axis. Eur Rev Med Pharmacol Sci 25(1):86–93 Liu DY, Li Z, Zhang K, Jiao N, Lu DG, Zhou DW, Meng YB, Sun L (2021) Circular RNA CircMTO1 suppressed proliferation and metastasis of osteosarcoma through miR-630/KLF6 axis. Eur Rev Med Pharmacol Sci 25(1):86–93
35.
go back to reference Liu X, Wu W, Zhang S, Tan W, Qiu Y, Liao K, Yang K (2021) Effect of miR-630 expression on esophageal cancer cell invasion and migration. J Clin Lab Anal 35(6):e23815CrossRef Liu X, Wu W, Zhang S, Tan W, Qiu Y, Liao K, Yang K (2021) Effect of miR-630 expression on esophageal cancer cell invasion and migration. J Clin Lab Anal 35(6):e23815CrossRef
36.
go back to reference Gong XF, Yu AL, Tang J, Wang CL, He JR, Chen GQ, Zhao Q, He M, Zhou CX (2018) MicroRNA-630 inhibits breast cancer progression by directly targeting BMI1. Exp Cell Res 362(2):378–385CrossRef Gong XF, Yu AL, Tang J, Wang CL, He JR, Chen GQ, Zhao Q, He M, Zhou CX (2018) MicroRNA-630 inhibits breast cancer progression by directly targeting BMI1. Exp Cell Res 362(2):378–385CrossRef
37.
go back to reference Li YH, Xu CL, He CJ, Pu HH, Liu JL, Wang Y (2020) circMTDH.4/miR-630/AEG‑1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC. Mol Carcinog 59(2):141–153CrossRef Li YH, Xu CL, He CJ, Pu HH, Liu JL, Wang Y (2020) circMTDH.4/miR-630/AEG‑1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC. Mol Carcinog 59(2):141–153CrossRef
38.
go back to reference Jin X, Yuan L, Liu B, Kuang Y, Li H, Li L, Zhao X, Li F, Bing Z, Chen W et al (2020) Integrated analysis of circRNA-miRNA-mRNA network reveals potential prognostic biomarkers for radiotherapies with X‑rays and carbon ions in non-small cell lung cancer. Ann Transl Med 8(21):1373CrossRef Jin X, Yuan L, Liu B, Kuang Y, Li H, Li L, Zhao X, Li F, Bing Z, Chen W et al (2020) Integrated analysis of circRNA-miRNA-mRNA network reveals potential prognostic biomarkers for radiotherapies with X‑rays and carbon ions in non-small cell lung cancer. Ann Transl Med 8(21):1373CrossRef
40.
go back to reference Li F, Zhou X, Chen M, Fan W (2020) Regulatory effect of LncRNA DRAIC/miR-149-5p/NFIB molecular network on autophagy of esophageal cancer cells and its biological behavior. Exp Mol Pathol 116:104491CrossRef Li F, Zhou X, Chen M, Fan W (2020) Regulatory effect of LncRNA DRAIC/miR-149-5p/NFIB molecular network on autophagy of esophageal cancer cells and its biological behavior. Exp Mol Pathol 116:104491CrossRef
41.
go back to reference Yang H, Wu Z, Liu X, Chen M, Zhang X, Jiang Y (2021) NFIB promotes the progression of gastric cancer by upregulating circMAP7D1 to stabilize HER2 mRNA. Mol Med Rep 23(4):269CrossRef Yang H, Wu Z, Liu X, Chen M, Zhang X, Jiang Y (2021) NFIB promotes the progression of gastric cancer by upregulating circMAP7D1 to stabilize HER2 mRNA. Mol Med Rep 23(4):269CrossRef
42.
go back to reference Li R, Wang X, Zhao X, Zhang X, Chen H, Ma Y, Liu Y (2020) Centromere protein F and forkhead box M1 correlation with prognosis of non-small cell lung cancer. Oncol Lett 19(2):1368–1374 Li R, Wang X, Zhao X, Zhang X, Chen H, Ma Y, Liu Y (2020) Centromere protein F and forkhead box M1 correlation with prognosis of non-small cell lung cancer. Oncol Lett 19(2):1368–1374
43.
go back to reference Alagia A, Eritja R (2016) siRNA and RNAi optimization. Wiley Interdiscip Rev RNA 7(3):316–329CrossRef Alagia A, Eritja R (2016) siRNA and RNAi optimization. Wiley Interdiscip Rev RNA 7(3):316–329CrossRef
44.
go back to reference Zhang MM, Bahal R, Rasmussen TP, Manautou JE, Zhong XB (2021) The growth of siRNA-based therapeutics: updated clinical studies. Biochem Pharmacol 189:114432CrossRef Zhang MM, Bahal R, Rasmussen TP, Manautou JE, Zhong XB (2021) The growth of siRNA-based therapeutics: updated clinical studies. Biochem Pharmacol 189:114432CrossRef
Metadata
Title
CircDLG1 promotes malignant development of non-small cell lung cancer through regulation of the miR-630/CENPF axis
Authors
Yingying Chen
Ying Zhang
Publication date
24-06-2022
Publisher
Springer Berlin Heidelberg
Keywords
NSCLC
NSCLC
Published in
Strahlentherapie und Onkologie / Issue 2/2023
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-022-01965-8

Other articles of this Issue 2/2023

Strahlentherapie und Onkologie 2/2023 Go to the issue